News

Newcastle pharmacy experts work with Italian biotech lab to provide access to sight-saving treatment across England

Holostem Terapie Avanzate begins its transition to a Foundation

Gene therapy for butterfly children: 5-year follow-up published in the New England Journal of Medicine

European Biotech Week: Holostem virtually opens its doors to the public

Holostem at the second asset talk organised by Clust-ER Health

Holoclar is now available also in Czech Republic

Michele De Luca wins an ERC Advanced Grant

Italy on the Move 2021: round table in the context of J.P. Morgan Annual Healthcare Conference

Graziella Pellegrini wins the first European Tech Women Award

Chiesi Group and Holostem Terapie Avanzate announce transfer of Holoclar® from the Chiesi Group to Holostem